Our customer services representatives are available 24 hours a day, from Monday to Sunday.
CONTACT USAbbreviation SBECD
Catalog CD182410000
CAS Number 182410-00-0
Cyclodextrin Type Anionic cyclodextrins
Packaging 20 kg
Storage Condition Store at room temperature, in tightly closed container
Availability In stock
*On-demand pack size is available, please contact us for multi-kilograms pack sizes.
Description
Parameters
Applications
Related Products
Case Study
Sulfobutylether-beta-cyclodextrin sodium salt, also abbreviated as SBECD, is an anionic CD derived from glucose. Its molecular structure is shaped like a tapered cylinder with a cavity that can include other guest molecules. SBECD is a β-CD derivative obtained by replacing native β-CD with sulfobutyl ether groups and sodium ions along the length of the molecule. Considering the cost, cavity size, and toxic effects of native CDs, SBECD with superior solubility properties was developed. As a commonly used pharmaceutical CD, SBECD is primarily used to enhance the solubility of poorly soluble drugs as an excipient or formulation [1].
Average Molecular Formula | C42H70-nO35·(C4H8O3SNa)n |
Average Molecular Weight | 1135.0 + n·(158.2) |
Average Degree of Substitution [DS] | 6.2-6.9 |
Possible Impurities | 4-Hydroxybutane-1-sulfonic acid sodium salt, bis(4-sulfobutyl) ether disodium, residual beta-cyclodextrin |
Solubility (in 100 cm3 solvent, at 25 °C) | Water: > 50 g Methanol: < 0.5 g Acetone: < 0.5 g |
Physical & Chemical Properties
Appearance | White or off-white powder |
Content | 95.0% - 105.0% |
Appearance of aqueous solution (30%, w/v) | The solution is clear. |
pH (30%, w/v) | 4.0-6.8 |
Loss on drying | Max. 10.0% |
Peak Distribution
*Each SBECD peak (I-X) meets the limit range (peak area %) of the Monograph
SBECD sodium peaks | I (DS-1) | II (DS-2) | III (DS-3) | IV (DS-4) | V (DS-5) | VI (DS-6) | VII (DS-7) | VIII (DS-8) | IX (DS-9) | X (DS-10) |
Limit range(% peak area) | 0-0.3 | 0-0.9 | 0.5-5.0 | 2.0-10.0 | 10.0-20.0 | 15.0-25.0 | 20.0-30.0 | 10.0-25.0 | 2.0-12.0 | 0-4.0 |
Identification
Identification: IR | Conforms with SBECD reference |
Identification: HPLC | tR of major peak conforms with SBECD reference |
Identification: Average degree of substitution | Meet requirements |
Identification: Sodium test | Positive test for sodium |
Impurities
Residual beta-cyclodextrin (β-CD) | Max. 0.1% |
Residual 1,4-butane sultone | Max. 0.5 ppm |
Residual sodium chloride | Max. 0.2% |
Residual 4-Hydroxybutane-1-sulfonic Acid | Max. 0.09% |
Residual Bis(4-sulfobutyl) Ether Disodium | Max. 0.05% |
Heavy metals | Max. 5 ppm |
Microorganism
Total aerobic microbial count (TAMC) | Max. 100 cfu/g |
Total yeast and mold count (TYMC) | Max. 50 cfu/g |
Escherichia coli | Not detectable |
SBECD has excellent solubility and is mainly used for the solubilization of drugs. Some drugs with a lipophilic or high molecular weight have poor water solubility and low bioavailability, which limits their application [1]. As an excipient, SBECD improves the solubility of drugs, offering an option for developing effective drug candidates. Currently, SBECD is used in a drug called Voriconazole.
As one of the leading CD companies, Alfa Chemistry has a dedicated team which has accumulated extensive expertise in the field of CD chemistry. We offer high quality SBECDs in multi-kilogram quantities tailored to the special needs of the pharmaceutical and other industries. We do our best to provide customers with first-class products and services. For more information, please feel free to contact us.
References
SBECD for Enhancing the Solubility and Oral Bioavailability of Niclosamide through Complexation
Kulkarni M, et al. Materials Today Communications, 2024, 39, 109202.
Sulfobutylether-β-cyclodextrin sodium (SBECD) was employed to form inclusion complexes with Niclosamide monohydrate (NCL), aiming to improve the solubility, dissolution rate, and oral bioavailability of NCL. Various preparation methods were used to form the NCL-SBECD complexes, including co-grinding, kneading, solvent evaporation, and spray drying, with a 1:1 molar ratio of NCL to SBECD. The co-ground complex was prepared by manually mixing NCL and SBECD in a mortar for 10 minutes. The kneaded complex involved mixing the NCL-SBECD mixture with a hydroalcoholic solution, followed by drying and sieving. For the co-evaporated complex, NCL was dissolved in acetone, and SBECD was dissolved in water, with the solvent mixture evaporated under controlled conditions at 60°C. The spray dried complex was prepared by dissolving NCL and SBECD in acetone and water, respectively, followed by mixing and drying using a spray dryer under specific operational conditions, including a feed rate of 12 mL/min, inlet temperature of 120°C, and outlet temperature of 60°C. These findings highlight the potential of SBECD as a versatile excipient in drug delivery systems to improve the therapeutic effectiveness of poorly soluble drugs.
It should be noted that our our products and services are for research use only, not for clinical use.
Privacy Policy | Cookie Policy | Copyright © 2025 Alfa Chemistry. All rights reserved.